Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Clinical trial NCT05340985 · UNKNOWN

Trial details

NCT number: NCT05340985
Sponsor: Tehran University of Medical Sciences
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Adult ALL Vitamin D3 Deficiency

Start date: 2022-07-01
Primary completion: 2023-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.